GlaxoSmithKline set to win Human Genome with enhanced offer say reports
05:34 EDT 16 Jul 2012 | Proactive Investors
GlaxoSmithKline (LON:GSK) is expected to tie-up the acquisition of partner Human Genome Sciences (NASDAQ:HGSI) today with an enhanced bid of up to $3 billion. The UK giant had a US$2.6 bln hostile bid rejected by the HGS board in April, which said t..
Original Article: GlaxoSmithKline set to win Human Genome with enhanced offer say reports
More From BioPortfolio on "GlaxoSmithKline set to win Human Genome with enhanced offer say reports"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
